P.023 Eculizumab Shows Consistent Improvements Across Muscle Groups in Patients With AChR Antibody-Positive Refractory Myasthenia Gravis

Canadian Journal of Neurological Sciences - United Kingdom
doi 10.1017/cjn.2019.123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Complete Remission Induced by Rituximab in Refractory, Seronegative, Muscle-Specific, Kinase-Positive Myasthenia Gravis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2006English

Treatment for Refractory Myasthenia Gravis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Rippling Muscle Disease With Myasthenia Gravis

2020English

Understanding the Burden of Refractory Myasthenia Gravis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2019English

Long-Term Treatment of Refractory Myasthenia Gravis With Subcutaneous Immunoglobulin

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2017English

Endotracheal Intubation Without the Use of Muscle Relaxants in Patients With Myasthenia Gravis

Medicinski Pregled
Medicine
2009English

Employment in Refractory Myasthenia Gravis: An Mgfa Registry Analysis

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2019English

Escalation Strategies in the Treatment of Refractory Myasthenia Gravis

Neurology International Open
2018English

Refractory Myasthenia Gravis: Clinical Description and Literature Review

Scholars Journal of Applied Medical Sciences
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy